Evidence-gap map · non-drug interventions

Polycystic Ovary Syndrome evidence gaps

244 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Polycystic Ovary Syndrome

Which non-drug approaches have been tested for Polycystic Ovary Syndrome, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

244registered non-drug trials
13with results posted
27recruiting as of 2026-11-16
71group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Polycystic Ovary Syndrome by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (44)1·25··21 with results117211 with results102 with results2·47
Rehabilitation and therapy services (1)···········1····
Breathing and respiratory training (1)·····1··········
Mind-body and psychological approaches (16)1·372·21·2651·11
Cognitive training and education (24)··23·11··4101 with results4··171 with results
Diet, fasting and nutrition (50)··11··32·133162·112
Sleep and circadian approaches (2)·····11 with results····22 with results·····
Oxygen, light, temperature and manual therapies (28)···122·1·11441··91 with results
Supplements and nutraceuticals (85)··571 with results1·33·2292 with results232 with results411311 with results
Other devices and digital tools (1)···········1····
Other behavioural, not yet classified (23)··23··31 with results··21151 with results1·25

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Neuromodulation and electrical stimulation; Care delivery and health services.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 28 trials of oxygen, light, temperature and manual therapies found, none used cognition as a primary outcome (14 trials of other approaches did).
  • Among the 28 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (13 trials of other approaches did).
  • Among the 24 trials of cognitive training and education found, none used symptom severity and disease activity as a primary outcome (10 trials of other approaches did).
  • Among the 24 trials of cognitive training and education found, none used heart rate, blood pressure and autonomic as a primary outcome (7 trials of other approaches did).
  • Among the 50 trials of diet, fasting and nutrition found, none used pain as a primary outcome (5 trials of other approaches did).
  • Among the 44 trials of exercise and physical activity found, none used pain as a primary outcome (5 trials of other approaches did).
  • Among the 24 trials of cognitive training and education found, none used pain as a primary outcome (5 trials of other approaches did).
  • Among the 85 trials of supplements and nutraceuticals found, none used sleep as a primary outcome (4 trials of other approaches did).
  • Among the 50 trials of diet, fasting and nutrition found, none used sleep as a primary outcome (4 trials of other approaches did).
  • Among the 44 trials of exercise and physical activity found, none used sleep as a primary outcome (4 trials of other approaches did).
  • Among the 16 trials of mind-body and psychological approaches found, none used sleep as a primary outcome (4 trials of other approaches did).

Questions studied but with no results posted

  • Diet, fasting and nutrition × weight and metabolic markers: 33 trials registered, none with results posted (2 still recruiting)
  • Diet, fasting and nutrition × inflammation and other biomarkers: 16 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × weight and metabolic markers: 14 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × quality of life: 7 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 7 trials registered, none with results posted
  • Mind-body and psychological approaches × weight and metabolic markers: 6 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × mood, anxiety and wellbeing: 5 trials registered, none with results posted
  • Mind-body and psychological approaches × inflammation and other biomarkers: 5 trials registered, none with results posted (1 still recruiting)
  • Supplements and nutraceuticals × cognition: 5 trials registered, none with results posted
  • Exercise and physical activity × feasibility, adherence and safety: 4 trials registered, none with results posted (1 still recruiting)
  • Cognitive training and education × quality of life: 4 trials registered, none with results posted
  • Cognitive training and education × inflammation and other biomarkers: 4 trials registered, none with results posted
  • Oxygen, light, temperature and manual therapies × inflammation and other biomarkers: 4 trials registered, none with results posted
  • Supplements and nutraceuticals × symptom severity and disease activity: 4 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Polycystic Ovary Syndrome

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 67 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.